339 related articles for article (PubMed ID: 8120408)
21. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B.
Abe J; Forrester J; Nakahara T; Lafferty JA; Kotzin BL; Leung DY
J Immunol; 1991 Jun; 146(11):3747-50. PubMed ID: 1903412
[TBL] [Abstract][Full Text] [Related]
22. Species-dependent post-translational modification and position 2 allelism: effects on streptococcal superantigen SSA structure and V beta specificity.
Stevens KR; Van M; Lamphear JG; Orkiszewski RS; Ballard KD; Cook RG; Rich RR
J Immunol; 1996 Sep; 157(6):2479-87. PubMed ID: 8805648
[TBL] [Abstract][Full Text] [Related]
23. Recombinant tetravalent group A streptococcal M protein vaccine.
Dale JB; Chiang EY; Lederer JW
J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
[TBL] [Abstract][Full Text] [Related]
24. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.
Tomai MA; Schlievert PM; Kotb M
Infect Immun; 1992 Feb; 60(2):701-5. PubMed ID: 1530928
[TBL] [Abstract][Full Text] [Related]
25. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
26. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.
Schmidt KH; Gerlach D; Wollweber L; Reichardt W; Mann K; Ozegowski JH; Fleischer B
Infect Immun; 1995 Dec; 63(12):4569-75. PubMed ID: 7591107
[TBL] [Abstract][Full Text] [Related]
27. Identification of two V beta 7-specific viral superantigens.
Ignatowicz L; Kappler JW; Marrack P; Scherer MT
J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
[TBL] [Abstract][Full Text] [Related]
28. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project.
Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M
J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SpeA) and the human T-cell receptor.
Kline JB; Collins CM
Mol Microbiol; 1997 Apr; 24(1):191-202. PubMed ID: 9140976
[TBL] [Abstract][Full Text] [Related]
30. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
[TBL] [Abstract][Full Text] [Related]
31. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
Vollmer J; Weltzien HU; Moulon C
J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
[TBL] [Abstract][Full Text] [Related]
32. Residues near the amino and carboxyl termini of staphylococcal enterotoxin E independently mediate TCR V beta-specific interactions.
Lamphear JG; Mollick JA; Reda KB; Rich RR
J Immunol; 1996 Mar; 156(6):2178-85. PubMed ID: 8690907
[TBL] [Abstract][Full Text] [Related]
33. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein.
Dong RP; Kamikawaji N; Toida N; Fujita Y; Kimura A; Sasazuki T
J Immunol; 1995 May; 154(9):4536-45. PubMed ID: 7536773
[TBL] [Abstract][Full Text] [Related]
34. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
35. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
Thakur A; Singhal S; Prakash K
J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254
[TBL] [Abstract][Full Text] [Related]
36. Similar superantigen gene profiles and superantigen activity in norwegian isolates of invasive and non-invasive group a streptococci.
Michaelsen TE; Andreasson IK; Langerud BK; Caugant DA
Scand J Immunol; 2011 Nov; 74(5):423-9. PubMed ID: 21707691
[TBL] [Abstract][Full Text] [Related]
37. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States.
Shulman ST; Stollerman G; Beall B; Dale JB; Tanz RR
Clin Infect Dis; 2006 Feb; 42(4):441-7. PubMed ID: 16421785
[TBL] [Abstract][Full Text] [Related]
38. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
39. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
[TBL] [Abstract][Full Text] [Related]
40. Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae.
Zhao J; Hayashi T; Saarinen S; Papageorgiou AC; Kato H; Imanishi K; Kirikae T; Abe R; Uchiyama T; Miyoshi-Akiyama T
Infect Immun; 2007 Apr; 75(4):1721-9. PubMed ID: 17283088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
